1. SymPathatic Sysytem ---------------- AdrenoReceptor
1.1. ß1
1.1.1. Agonist
1.1.1.1. Epinehren
1.1.1.2. Norepinephren
1.1.1.3. Dopamine
1.1.2. Antaagonist
1.1.2.1. Labetalol
1.1.2.2. Metoprolol
1.1.3. 1-Tachycardia 2-Increased myocardial contractility 3- Increased release or renin
1.2. ß1
1.2.1. Agonist
1.2.1.1. Epinehren
1.2.1.2. Norepinephren
1.2.1.3. Dopamine
1.2.2. Antaagonist
1.2.2.1. Labetalol
1.2.2.2. Metoprolol
1.2.3. 1-Tachycardia 2-Increased myocardial contractility 3- Increased release or renin
1.3. ß1
1.3.1. Agonist
1.3.1.1. Epinehren
1.3.1.2. Norepinephren
1.3.1.3. Dopamine
1.3.2. Antaagonist
1.3.2.1. Labetalol
1.3.2.2. Metoprolol
1.3.3. 1-Tachycardia 2-Increased myocardial contractility 3- Increased release or renin
1.4. ß1
1.4.1. Agonist
1.4.1.1. Epinehren
1.4.1.2. Norepinephren
1.4.1.3. Dopamine
1.4.2. Antaagonist
1.4.2.1. Labetalol
1.4.2.2. Metoprolol
1.4.3. 1-Tachycardia 2-Increased myocardial contractility 3- Increased release or renin
2. SymPathatic Sysytem ---------------- AdrenoReceptor
2.1. ß1
2.1.1. Agonist
2.1.1.1. Epinehren
2.1.1.2. Norepinephren
2.1.1.3. Dopamine
2.1.2. Antaagonist
2.1.2.1. Labetalol
2.1.2.2. Metoprolol
2.1.3. 1-Tachycardia 2-Increased myocardial contractility 3- Increased release or renin
2.2. ß2
2.2.1. Agonist
2.2.1.1. Albuterol
2.2.2. Antaagonist
2.2.2.1. Lebatolo
2.2.3. 1-Broncho dialation 2-Vaso dialation
2.3. a1
2.3.1. Agonist
2.3.1.1. Epinehren
2.3.1.2. Dopamine
2.3.2. Antaagonist
2.3.2.1. Labetalol
2.3.3. 1-Vaso constriction 2-Increased Blood Pressure
2.4. a2
2.4.1. Inhibition of Insuline